View by type:
Articles (4214)
New supply agreement between UNICEF and Serum Institute of India (SII) makes pneumococcal conjugate vaccine (PCV) available at US$2.00 per dose, a 43% reduction from the Gavi price at the start of the AMC
Vaccinations and COVID-19: What parents need to know
How to safely get routine vaccinations for your child during the COVID-19 pandemic
When it comes to COVID-19 vaccines how can governments back a winner?
With so many COVID-19 candidate vaccines in development, and with most of them likely to fail, what’s the best way for governments to ensure they back a winner and ensure there are enough doses for everyone?
A third of the world has been under some form of lockdown to tackle the COVID-19 pandemic, but has it made any difference to the number of cases and deaths?
How digital tools are helping Pakistan monitor routine immunisation during the pandemic
A Gavi-supported digital immunisation registry is keeping track of vaccination activities to make sure children remain protected from other infectious diseases.
5 reasons why pandemics like COVID-19 are becoming more likely
SARS, Ebola, Zika, and now COVID-19. Five reasons why disease epidemics and even pandemics are becoming increasingly common.
How are Gavi's private sector partners stepping up to help fight COVID-19?
Despite the devastating economic impact this pandemic has had on businesses across the world, many are doing their part to bring this crisis to an end.
Could COVID-19 ever be eradicated?
Ideally, humanity would end COVID-19 by eradicating it so there are no new cases globally even in the absence of preventive measures. However, experience with other disease eradication programmes indicates that this will be very challenging, and…
How the world changed on 4 June
On 4 June, global leaders met at a virtual event to pledge support for Gavi, the Vaccine Alliance, and in the process made history by reaching new global health milestones
02 June 2020: Overview of the COVID-19 situation in Gavi-supported countries and Gavi’s response
Seventy (out of 73) Gavi-eligible countries have reported 475,401 confirmed cases and 12,464 deaths. Though this number still accounts for a small proportion, about 7%, of global COVID-19 cases, this share is expected to increase given the…
World leaders make historic commitments to provide equal access to vaccines for all
The Global Vaccine Summit, hosted by the UK, raises US$ 8.8 billion from 32 donor governments and 12 foundations, corporations and organisations to immunise 300m children and support the global fight against COVID-19.
Gavi launches innovative financing mechanism for access to COVID-19 vaccines
Gavi Advance Market Commitment for COVID-19 Vaccines (Gavi Covax AMC) launched at Global Vaccine Summit 2020 draws strong support, early commitments from global leaders.